**Core Concept**
Spider naevi are small, dilated blood vessels near the surface of the skin, often associated with liver disease. The underlying principle being tested is the mechanism of vasodilation in these lesions.

**Why the Correct Answer is Right**
The correct answer is related to the role of **histamine** in vasodilation. Histamine is a potent vasodilator that acts on H1 receptors to cause blood vessel dilation. In spider naevi, histamine release from **mast cells** contributes to the characteristic flushing and dilatation of blood vessels. This histamine-mediated response is a key factor in the pathophysiology of spider naevi.

**Why Each Wrong Option is Incorrect**
**Option A:** This option might be incorrect as it does not specify a well-known mechanism of vasodilation in spider naevi. While prostaglandins and thromboxanes do play roles in vasodilation, they are not primarily associated with the pathophysiology of spider naevi.

**Option B:** This option might be incorrect as it refers to a different type of vasodilation. The nitric oxide-cyclic guanosine monophosphate (NO-cGMP) pathway is a well-known mechanism of vasodilation, but it is not directly related to the pathophysiology of spider naevi.

**Option C:** This option might be incorrect as it does not accurately describe the pathophysiology of spider naevi. The liver disease-association of spider naevi is well-established, but the exact mechanism of vasodilation is more closely related to histamine release than to liver disease itself.

**Clinical Pearl / High-Yield Fact**
A classic exam trap to watch out for is the association of spider naevi with liver disease. While liver disease is indeed a risk factor for spider naevi, the primary pathophysiological mechanism is histamine-mediated vasodilation, not liver disease per se.

**Correct Answer:** D. Histamine release from mast cells.